glp-1/gip peptide Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Review Article: GLP-1 Receptor Agonists

This might be due to variations in patient characteristics, the severity of acne at baseline, or metabolic reactions (e.g., insulin alterations, weight loss)

Data availability The EHR database used in this study were obtained from TriNetX ( Abbreviations GLP-1RAs: Glucagon-like peptide-1 receptor agonists T2DM: Type 2 diabetes mellitus EHRs: Electronic health records SGLT2: Sodium-glucose cotransporter-2 DPP-4: Dipeptidyl peptidase-4 HR: Hazard ratios CI: Confidence intervals References Alfaris N, Waldrop S, Johnson V, Boaventura B, Kendrick K, Stanford FC (2024) GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review

Primary ciliary dyskinesia (PCD) is a rare autosomal recessive genetic disorder caused by malfunctioning motile cilia, primarily affecting the respiratory system

Comorbid depression and diabetes worsen glycemic control, and certain antidepressants may inversely contribute to it

Together, we'll create a customized strategy that incorporates nutrient-dense meal plans, achievable exercise routines, and practical lifestyle changes that seamlessly fit into your daily rhythms